ELYM Eliem Therapeutics Inc.: Nilai bisnis marang pendapatan

Logo perusahaan publik Eliem Therapeutics (ELYM)

Risks for Eliem Therapeutics (ELYM) are linked to scientific uncertainty and the absence of stable revenue. Business dynamics depend on clinical data rather than market cycles. The EV/Sales valuation multiple reflects the market's reaction to news, with the metric currently standing at . Updated management is currently integrating assets, awaiting investor valuation of its achievements in neuroscience.

ELYM Rasio nilai perusahaan marang pendapatan Eliem Therapeutics (04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar Eliem Therapeutics (ELYM)

- data kapitalisasi saham perusahaan:
Barang utama Eliem

This ratio relates the total enterprise value, including debt and cash, to sales volume, allowing for an assessment of the asset's real value regardless of financial leverage. By analyzing the EV/Sales chart, an investor can identify critical undervaluation or the risk of default for Eliem Therapeutics (ELYM), whose capitalization currently depends on external financing due to a lack of stable revenue and high uncertainty surrounding clinical trials.

Analisis pesaing Eliem Therapeutics

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|NRSN - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales RVPH (Reviva Pharmaceuticals Holdings Inc.)|Koefisien nilai perusahaan marang pendapatan MTVA (metaviatx.com)|NeurAxis Inc. - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan heliusmedical.com HSDT|PASG: Multiplikator EV/Sales|Neuphoria - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NERV|ATHA: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCN (cyclerion.com)|Rasio nilai perusahaan marang dodolan Protagenic|KTTA: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan CRGT (cortigent.com)|ATXI: Multiplikator EV/Sales|BCLI (BrainStorm Cell Therapeutics) - Rasio nilai perusahaan marang pendapatan|CARA (Cara Therapeutics Inc.) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan CHRO|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE